Doxycycline Patent Expiration
Doxycycline is Used for treating inflammatory lesions of rosacea. It was first introduced by Pfizer Laboratories Div Pfizer Inc
Doxycycline Patents
Given below is the list of patents protecting Doxycycline, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Oracea | US10058564 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
| Oracea | US5789395 | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
Aug 30, 2016
(Expired) | Galderma Labs Lp |
| Oracea | US5919775 | Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
Aug 30, 2016
(Expired) | Galderma Labs Lp |
| Oracea | US7211267 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
| Oracea | US7232572 | Methods of treating rosacea |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
| Oracea | US7749532 | Once daily formulations of tetracyclines | Dec 19, 2027 | Galderma Labs Lp |
| Oracea | US8206740 | Once daily formulations of tetracyclines | Dec 24, 2025 | Galderma Labs Lp |
| Oracea | US8394405 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
| Oracea | US8394406 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
| Oracea | US8470364 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
| Oracea | US8603506 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
| Oracea | US8709478 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
| Oracea | US9241946 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Doxycycline Generics
Several generic applications have been filed for Doxycycline. The first generic version for Doxycycline was by Rachelle Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jun 27, 2024.
Given below is the list of companies who have filed for Doxycycline generic.
1. LUPIN
Lupin Inc has filed for 1 generic for Doxycycline. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | capsule | Prescription | ORAL | AB | Apr 8, 2024 |
2. HERITAGE PHARMS
Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Heritage Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2011 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2011 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Dec 20, 2011 |
| EQ 150MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Dec 20, 2011 |
3. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Dec 15, 2000 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Dec 15, 2000 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Apr 18, 2005 |
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Jun 8, 2012 |
4. LANNETT CO INC
Lannett Co Inc has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Dec 8, 2005 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Dec 8, 2005 |
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Jul 30, 2008 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jul 30, 2008 |
5. COSETTE
Cosette Pharmaceuticals Inc has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | May 28, 2015 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | May 28, 2015 |
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | May 28, 2015 |
6. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2017 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Jul 28, 2017 |
| 40MG | capsule | Prescription | ORAL | AB | Jun 27, 2024 |
7. WATSON LABS
Watson Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Apr 28, 2000 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Apr 28, 2000 |
8. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE/5ML
(reference standard) | for suspension | Prescription | ORAL | AB | Mar 18, 2013 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 5, 2014 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 5, 2014 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 5, 2014 |
9. RACHELLE
Rachelle Laboratories Inc has filed for 1 generic for Doxycycline. This eq 25mg base/5ml version comes by the name DOXYCHEL. Given below are the details of the strengths of this generic introduced by Rachelle.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
10. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 31, 2006 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 31, 2006 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | May 31, 2006 |
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Jul 29, 2010 |
11. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
| EQ 150MG BASE | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
12. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Sep 29, 2017 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Sep 29, 2017 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Sep 29, 2017 |
13. CHARTWELL
Chartwell Scheduled Llc has filed for 1 generic for Doxycycline. Given below are the details of the strengths of this generic introduced by Chartwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 25MG BASE/5ML | for suspension | Prescription | ORAL | AB | Jul 16, 2008 |
14. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Apr 17, 2009 |
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Apr 17, 2009 |
| EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Apr 17, 2009 |
15. IMPAX LABS INC
Impax Laboratories Inc has filed for 1 generic for Doxycycline. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 150MG BASE | capsule | Discontinued | ORAL | N/A | Feb 17, 2011 |
16. SANDOZ INC
Sandoz Inc has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Sandoz Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Nov 27, 2006 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Nov 27, 2006 |
| EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Nov 27, 2006 |
17. APPCO
Appco Pharma Llc has filed for 4 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Appco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Discontinued | ORAL | N/A | Nov 7, 2006 |
| EQ 100MG BASE | tablet | Discontinued | ORAL | N/A | Nov 7, 2006 |
| EQ 75MG BASE | tablet | Discontinued | ORAL | N/A | Nov 7, 2006 |
| EQ 150MG BASE | tablet | Discontinued | ORAL | N/A | Jun 7, 2007 |
18. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Doxycycline. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | capsule | Prescription | ORAL | AB | Jul 1, 2010 |
19. RISING
Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Doxycycline. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Jan 21, 2021 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Jan 21, 2021 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Jan 21, 2021 |
20. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Doxycycline. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 40MG | capsule | Prescription | ORAL | AB | Apr 8, 2024 |